We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Branched Stent-Grafts Preferred to Open Vascular Surgery

By HospiMedica staff writers
Posted on 11 Jun 2007
A modular stent-graft that incorporates multiple caudally-directed branches to the visceral arteries can offer a safer surgical alternative to open repair for thoracoabdominal aortic aneurysm (TAAA), according to a new study. More...


University of California San Francisco (UCSF; USA) researchers reported the results of surgery in 16 patients (all unfit for open repair) who were successfully treated with self-expanding covered stents connecting the caudally-directed cuffs of an aortic stent-graft with the visceral branches of an aortic aneurysm (57 branches in all). The technique employed "springy” grafts with overlapping segments where the components meet; the branches of the stent-graft curve downwards and outwards from the main trunk, mimicking the branching pattern of a normal thoracoabdominal aorta. The customized aortic stent-grafts were inserted through the femoral or iliac arteries, while covered stents were inserted through the brachial arteries. Routine follow-up included contrast-enhanced computed tomography (CT) scans at one week, one month, six months, and one year.

The results showed that four patients had significant perioperative complications during follow-up (mean 180 days). Two with severe longstanding chronic obstructive pulmonary disease developed pneumonia; one developed paraplegia and renal failure and died after declining dialysis; and one underwent successful re-intervention for iatrogenic aortic dissection and for type 1 endoleak. There were no other cases of death, re-intervention, endoleak, stroke, or myocardial infarction. According to the researchers, the overall rate of perioperative death, paraplegia, stroke, or renal failure was 5% and no stent-graft had moved, leaked, came apart, kinked, occluded, or broke during follow-up. The study was presented at the 61st annual meeting of the Society for Vascular Surgery, held during June 2007 in Chicago, IL, USA.

"Open repair is difficult because the TAAA is inaccessible and also is dangerous because the operation requires a large incision and extensive dissection,” said lead author Timothy A.M. Chuter, M.D., a professor of surgery in residence in the division of vascular surgery at UCSF. "Additionally, with open repair, there is an interruption of blood flow to the lower half of the body, including abdominal organs.”

Dr. Chuter added that the less invasive approach eliminates aneurysm flow, while at the same time preserving visceral perfusion and avoiding the main physiologic stresses.


Related Links:
University of California San Francisco

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.